Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain DXCM message board posts where the ticker symbol DXCM has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest DXCM SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000098 Size: 6 KB
2018-05-17
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000097 Size: 6 KB
2018-05-17
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000094 Size: 9 KB
2018-05-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000092 Size: 6 KB
2018-05-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000090 Size: 21 KB
2018-05-10
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000089 Size: 8 KB
2018-05-10
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000086 Size: 10 KB
2018-05-09
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001093557-18-000084 (34 Act)  Size: 4 MB
2018-05-02 000-51222
18800814
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001093557-18-000079 (34 Act)  Size: 195 KB
2018-05-02 000-51222
18799629
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001093557-18-000072 Size: 5 KB
2018-04-25
More DXCM SEC Filings


Related news from
Thu, 17 May 2018
12:00:00 +0000
DexCom Announces Upcoming Conference Presentation
DexCom, Inc. today announced that management will present an update on DexCom at the following upcoming investor conference:
Sat, 12 May 2018
13:00:00 +0000
Dexcom's newest diabetes device can read your blood sugar without any blood, and it's a life-changer
CNBC’s Erin Black, who has Type 1 Diabetes, puts the Dexcom G6 to the test to see if it’s as accurate as previous glucose monitors that require a finger prick and blood.
Wed, 09 May 2018
12:04:35 +0000
See what the IHS Markit Score report has to say about Dexcom Inc.
Dexcom Inc NASDAQ/NGS:DXCM
Fri, 04 May 2018
14:31:32 +0000
Abbott’s Freestyle Libre CGM’s Performance, Growth Prospects
Abbott Laboratories (ABT) received FDA approval for its breakthrough CGM (continuous glucose monitoring) device, Freestyle Libre, in September 2017. For further details, please read Abbott’s Breakthrough CGM Device Freestyle Libre Wins FDA Approval. The company received reimbursement approval for the device from the Centers for Medicare & Medicaid Services in January 2018.
Fri, 04 May 2018
13:19:01 +0000
DexCom (DXCM) Meets Q1 Earnings Estimates, Raises '18 View
Solid contribution from Sensor revenues, Transmitter revenues and Receiver revenues drive DexCom's (DXCM) Q1 results.
Fri, 04 May 2018
02:05:31 +0000
Edited Transcript of DXCM earnings conference call or presentation 2-May-18 8:30pm GMT
Q1 2018 DexCom Inc Earnings Call
Thu, 03 May 2018
14:49:00 +0000
Here's Why DexCom Is Surging Today
Traders cheer after the company reports better-than-expected results and boosts guidance. Here's what investors need to know.
Wed, 02 May 2018
21:33:24 +0000
DexCom: 1Q Earnings Snapshot
On a per-share basis, the San Diego-based company said it had a loss of 28 cents. Losses, adjusted for non-recurring gains, came to 32 cents per share. The results met Wall Street expectations. The average ...
Wed, 02 May 2018
20:01:00 +0000
DexCom Reports First Quarter 2018 Financial Results
DexCom, Inc. today reported its unaudited financial results as of and for the quarter ended March 31, 2018.
Tue, 17 Apr 2018
11:30:00 +0000
New Research Coverage Highlights DexCom, Equinix, Fitbit, Gilead Sciences, Humana, and Microsoft — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, April 17, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Tue, 10 Apr 2018
20:58:30 +0000
Edited Transcript of DXCM presentation 6-Mar-17 9:00pm GMT
DexCom Inc at Raymond James Institutional Investors Conference
Tue, 10 Apr 2018
11:30:00 +0000
Free Research Report as DexCom’s Quarterly Revenues Surged 29%; Turned Profitable Y-O-Y
Stock Monitor: Cancer Genetics Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 10, 2018 / Active-Investors.com has just released a free earnings report on DexCom, Inc. (NASDAQ: DXCM ). If you want ...
Wed, 04 Apr 2018
19:35:00 +0000
Here's Why Senseonics Holdings Inc. Is Rising Today
Shares jump after the company receives some favorable commentary from a Wall Street analyst.
Wed, 04 Apr 2018
12:00:00 +0000
DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 p.m. Eastern Time.
DexCom, Inc. today announced that it plans to release its first quarter 2018 financial results after market close on Wednesday, May 2, 2018. Management will hold a conference call to review the company's first quarter 2018 performance starting at 4:30 p.m.
Thu, 29 Mar 2018
23:00:00 +0000
Cramer's lightning round: CVS' management is no good at t...
Jim Cramer shares his take on callers' favorite stocks at lightning speed, including a pharmacy operator's stock.
Thu, 29 Mar 2018
22:50:00 +0000
Cramer's lightning round: CVS' management is no good at telling their story
Jim Cramer shares his take on callers' favorite stocks at lightning speed, including a pharmacy operator's stock.
Wed, 28 Mar 2018
14:14:02 +0000
DexCom (DXCM) Gets FDA Approval for G6 CGM Monitoring System
DexCom (DXCM) is a leading player in the global CGM markets.
Tue, 27 Mar 2018
20:45:00 +0000
FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
DexCom, Inc. , the leader in continuous glucose monitoring is pleased to announce that the U.S. Food and Drug Administration has granted a De Novo request for the Dexcom G6® CGM System, the newest generation of CGM for people with diabetes ages 2 and up.
Tue, 27 Mar 2018
20:12:36 +0000
FDA approves DexCom's glucose monitoring system
The U.S. Food and Drug Administration on Tuesday approved DexCom Inc's monitoring system to check blood sugar levels in children and adults suffering from diabetes, which can be used along with devices such as insulin pumps. This is the first glucose monitoring system permitted by the agency that can be used with other compatible medical devices, the FDA said. A previous version of DexCom's monitoring system had received FDA approval in 2016 but was not designed to be used with other devices.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "Since being one of the beginning members, it has been a great experience. This select group of sophisticated investors has exceptional knowledge to share. The members come from all walks of life and have varied experiences. Many are experts in finance and commodity related issues. Many are good money managers. This is a value oriented group where good yields on a variety of stocks are the main focus." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards